Literature DB >> 15807538

Identification of the glycosylation site of the adenovirus type 5 fiber protein.

Gilles Cauet1, Jean-Marc Strub, Emmanuelle Leize, Elsa Wagner, Alain Van Dorsselaer, Monika Lusky.   

Abstract

The fiber protein purified from the pool of nonincorporated viral protein after infection of cells with adenovirus type 5 exists as two forms separable by reverse-phase HPLC. As determined by mass spectrometry, this heterogeneity results from a difference in one O-linked N-acetylglucosamine (GlcNac). A western blot analysis using a monoclonal antibody directed against the GlcNac motif showed that only one of the two forms reacted with the antibody, suggesting that one form carries a single GlcNac and the other form has none. The ratio of glycosylated to nonglycosylated forms of fiber, which is about 1, is conserved in assembled viruses. After digestion of glycosylated fiber with endoproteinase GluC, isolation of the glycosylated peptide by reverse-phase HPLC, and chemical derivatization using dimethylamine, the site of glycosylation was located in the fiber shaft at serine 109 by mass spectrometry. Elimination of glycosylation by site-directed mutagenesis of fiber should help to understand the function of this postranslational modification.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15807538     DOI: 10.1021/bi047702b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Characterization of the capsid protein glycosylation of adeno-associated virus type 2 by high-resolution mass spectrometry.

Authors:  Sarah Murray; Carol L Nilsson; Joan T Hare; Mark R Emmett; Andrei Korostelev; Heather Ongley; Alan G Marshall; Michael S Chapman
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Functional effects of coxsackievirus and adenovirus receptor glycosylation on homophilic adhesion and adenoviral infection.

Authors:  Katherine J D Ashbourne Excoffon; Nicholas Gansemer; Geri Traver; Joseph Zabner
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

3.  Chemoselective attachment of small molecule effector functionality to human adenoviruses facilitates gene delivery to cancer cells.

Authors:  Partha Sarathi Banerjee; Philomena Ostapchuk; Patrick Hearing; Isaac Carrico
Journal:  J Am Chem Soc       Date:  2010-10-06       Impact factor: 15.419

4.  Critical determinants of human α-defensin 5 activity against non-enveloped viruses.

Authors:  Anshu P Gounder; Mayim E Wiens; Sarah S Wilson; Wuyuan Lu; Jason G Smith
Journal:  J Biol Chem       Date:  2012-05-25       Impact factor: 5.157

5.  Delineation of interfaces on human alpha-defensins critical for human adenovirus and human papillomavirus inhibition.

Authors:  Victoria R Tenge; Anshu P Gounder; Mayim E Wiens; Wuyuan Lu; Jason G Smith
Journal:  PLoS Pathog       Date:  2014-09-04       Impact factor: 6.823

6.  Post-translational modifications in capsid proteins of recombinant adeno-associated virus (AAV) 1-rh10 serotypes.

Authors:  Bertin Mary; Shubham Maurya; Sathyathithan Arumugam; Vikas Kumar; Giridhara R Jayandharan
Journal:  FEBS J       Date:  2019-08-01       Impact factor: 5.622

7.  Protein crystals in Adenovirus type 5-infected cells: requirements for intranuclear crystallogenesis, structural and functional analysis.

Authors:  Laure Franqueville; Petra Henning; Maria Magnusson; Emmanuelle Vigne; Guy Schoehn; Maria E Blair-Zajdel; Nagy Habib; Leif Lindholm; G Eric Blair; Saw See Hong; Pierre Boulanger
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

8.  Site-Specific N-Glycosylation on the AAV8 Capsid Protein.

Authors:  Arya Aloor; Junping Zhang; Ebtesam A Gashash; Aishwarya Parameswaran; Matthew Chrzanowski; Cheng Ma; Yong Diao; Peng George Wang; Weidong Xiao
Journal:  Viruses       Date:  2018-11-17       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.